Lundberg Sven Ante — SEC Form 4 filings
SEC reporting owner CIK 1682126. 16 Form 4 filings on record with FilingPulse; latest filed 2026-07-21.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-03-27 to 2026-07-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 53.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Merus N.V. (MRUS) | President, CEO & PEO, Director | 7 | — | — | 33 |
| Q32 Bio Inc. (QTTB) | Director | 7 | — | — | 18 |
| Vor Biopharma Inc. (VOR) | Director | 2 | — | — | 2 |
Form 4 filings — Lundberg Sven Ante
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-21 | 4/A | Q32 Bio Inc. (QTTB) | Grant/award (A): 10,826 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Q32 Bio Inc. (QTTB) | Grant/award (A): 9,810 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Q32 Bio Inc. (QTTB) | Grant/award (A): 20,363 (derivative) @ $2.75 | EDGAR |
| 2025-12-12 | 4 | Merus N.V. (MRUS) | Code (U): 30,297 @ $97 · Code (U): 16,372 @ $97 · Code (U): 9,191 @ $97 · Code (U): 9,191 @ $97 · Code (U): 9,192 @ $97 · Code (U): 9,192 @ $97 · +6 more | EDGAR |
| 2025-11-28 | 4 | Merus N.V. (MRUS) | Gift (G): 30,297 @ $0 · Gift (G): 30,297 @ $0 · Gift (G): 14,198 @ $0 · Gift (G): 12,215 @ $0 · Gift (G): 52,369 @ $0 · Gift (G): 22,449 @ $0 · +5 more | EDGAR |
| 2025-10-27 | 4 | Q32 Bio Inc. (QTTB) | Grant/award (A): 53,521 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | Vor Biopharma Inc. (VOR) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-04-21 | 4 | Merus N.V. (MRUS) | Option exercise (M): 3,797 @ $12.54 · Option exercise (M): 26,500 @ $13.52 · Option exercise (M): 3,797 (derivative) @ $12.54 · Option exercise (M): 26,500 (derivative) @ $13.52 | EDGAR |
| 2025-02-26 | 4 | Q32 Bio Inc. (QTTB) | Disposition to issuer (D): 2,013 (derivative) @ $0 · Grant/award (A): 2,013 (derivative) @ $0 · Disposition to issuer (D): 6,238 (derivative) @ $0 · Grant/award (A): 6,238 (derivative) @ $0 · Disposition to issuer (D): 2,880 (derivative) @ $0 · Grant/award (A): 2,880 (derivative) @ $0 · +6 more | EDGAR |
| 2025-02-21 | 4 | Merus N.V. (MRUS) | Gift (G): 40,601 @ $0 · Gift (G): 40,601 @ $0 | EDGAR |
| 2025-02-18 | 4 | Merus N.V. (MRUS) | Option exercise (M): 16,372 @ $24.43 · Option exercise (M): 16,372 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Merus N.V. (MRUS) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2024-09-27 | 4 | Q32 Bio Inc. (QTTB) | Grant/award (A): 1,316 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Vor Biopharma Inc. (VOR) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-09 | 4 | Merus N.V. (MRUS) | Grant/award (A): 360,000 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | Q32 Bio Inc. (QTTB) | Grant/award (A): 12,767 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1682126 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →